The company in question is, Eli Lilly and Company (NYSE:LLY) currently with a stock price of 82.05 (0.00% today). The market cap for Eli Lilly and Company is 89.73 B, and is in the sector Healthcare, and Drug Manufacturers – Major industry. The target price for Eli Lilly and Company is 89.1. Currently Eli Lilly and Company is trading with a P/E of 39.85, and a forward P/E of 18.76. Average volume for Eli Lilly and Company is 3874.69 and so far today it is 0.
Performance in the last year for Eli Lilly and Company has been 11.31%. For EPS growth, Eli Lilly and Company has seen a growth of 14.10%, and is looking to grow in the next year to 6.19%. More long term stats show that EPS growth has been -8.00% over the last five years and could be 12.48% for the next five years. Eli Lilly and Company has seen sales growth quarter over quarter at 7.50%, with EPS growth quarter over quarter at -125.30%. The 20-day simple moving average is 3.32%, with the 200-day simple moving average coming to 4.48%.
Since the IPO date for Eli Lilly and Company on the 06/01/1972, Eli Lilly and Company has seen performance year to date to be 11.56%. With Eli Lilly and Company trading at 82.05, the dividend yield is 2.54%, and the EPS is 2.06.
So could Eli Lilly and Company, be undervalued? Well as said before P/E is 39.85. The PEG is 3.19, P/S is 4.16 and the P/B is at 6.18. The P/cash is 25.6, with P/free cash flow at 28.44.
Eli Lilly and Company ability to deal with debt shows that the current ratio is 1.2, and the quick ratio is 0.9. This is with long term debt/equity at 0.54, and total debt/equity at 0.73.
In terms of margins, Eli Lilly and Company has a gross margin of 73.80%, an operating margin of 12.90% and a profit margin of 10.10%.Payout ratio for Eli Lilly and Company is 99.20%. Return on assets come to 5.80% with return on investment coming to 11.60%.
Insider ownership for Eli Lilly and Company, is at 11.50% and institutional ownership comes to 77.60%. Outstanding shares are at 1093.57. While shares float is 1093.57. The float short is currently 0.93%, and short ratio is 2.63.
Graphs: Eli Lilly and Company NYSE: LLY | Friday June 16, 2017
Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.